Skip to content

Category: Top Stories

Micron has been on a tear. How to take profits and generate income on the chipmaker using options

Business Men Break Sit Read Newspaper

Jeff Kilburg breaks down how he’s defining his risk in MU.

ASML hits record high on AI boost — and analysts see plenty of room to run

Business Men Break Sit Read Newspaper

Dutch semiconductor equipment maker ASML became just the third European company to his a valuation of over $500 billion on Thursday.

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

Business Men Break Sit Read Newspaper

These are some of the stocks posting the largest moves in midday trading.

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

Business Men Break Sit Read Newspaper

The early data is a boost to the Danish drugmaker’s hopes of winning back more market share from Eli Lilly this year in the obesity drug space.

This gym stock could see a boost from increase weight-loss pill use, says Stifel

Business Men Break Sit Read Newspaper

Planet Fitness could be among the beneficiaries of the GLP-1 craze, according to Stifel.

Trump floats new tariffs in push to acquire Greenland

Business Men Break Sit Read Newspaper

The comments show Trump considering applying his aggressive tariff strategies to his efforts to acquire Greenland.

Warsh sprints ahead in Fed chair race following Trump comments on Hassett, prediction markets show

Business Men Break Sit Read Newspaper

Trump, without explicitly stating his decision, said he’d prefer to keep Hassett in his position as top economic advisor.

Friday, January 16, 2026: Jim Cramer discusses his next moves for the Investing Club

Business Men Break Sit Read Newspaper

Post Content

The biggest gains in early 2026 have come from small-cap stocks

Business Men Break Sit Read Newspaper

If the first few trading sessions of the year are any indication, 2026 is set to be the year of the small-cap trade.

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

Business Men Break Sit Read Newspaper

China is becoming a leader in biotech innovation. That offers hope to rare disease patients and presents a problem to American companies trying to save them.

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer